Clinical Trial Update: A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013) [Phase 3]

View source ↗

Summary

Phase 3 trial of the V116 vaccine for pneumococcal infection in children and teenagers has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• V116 vaccine

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infection | Phase 3 | Status: COMPLETED | Results posted: 2026-03-11